Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase II study of Fluvirin 2008-2009 formulation in non-elderly and elderly adults
2008-000939-17Phase 2Completed
- Sponsor
- Novartis
- Start
- Apr 2008
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 2, open-label trial of influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated) in influenza (2 arms), sponsored by Novartis. Primary endpoints: Antibody response by haemagglutination inhibition test, Serological criteria for each strain in non-elderly adults and 1 more. Started Apr 2008; status: completed.
02
Drugs
influenza a virus a/singapore/gp1908/2015 ivr-180 (h1n1) antigen (uv, formaldehyde inactivated)
03
Conditions
influenza
Beyond the preview
Go deeper on 2008-000939-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-000939-17.